PPDTM CorEvitasTM Vitiligo Drug Safety and Effectiveness Registry for Adults & Adolescents
RecruitingObservational studyHealthy volunteers welcome
Who can join
Ages 12 and older · All sexes · Healthy volunteers welcome
Full eligibility criteria
Inclusion Criteria: Individuals are eligible for enrollment if they meet all of the following criteria: * Have a dermatologist- or qualified dermatology practitioner-confirmed diagnosis of nonsegmental vitiligo (NSV). * Is at least 12 years of age or older at the time of enrollment. * Is willing and able to provide informed consent or assent, with parent/legal guardian consent as applicable. * Adult participants are willing and able to provide required personal information • Full legal name, sex, date of birth, and home ZIP/postal code * Meet the criteria for one of the following enrollment cohorts at the time of enrollment: Cohort 1: Eligible Medication Initiators - Individuals initiating a prescribed eligible NSV medication at the time of enrollment. Cohort 2: Not Initiating Eligible Medication - Individuals not currently receiving NSV medication at the time of enrollment, Individuals receiving eligible NSV medication prior to enrollment. Exclusion Criteria: An individual who meets any of the following criteria will be excluded from participation in the registry: \- Is participating or planning to participate in a blinded clinical trial for a vitiligo therapy.
About the study
The design is a prospective, observational (non-interventional) registry for adolescent and adult subjects with NSV under the care of a dermatology provider.
Sponsor: CorEvitas · Participants: 2,500 · Started: Aug 21, 2026
Contact the study team
- Vitiligo Registry Study Team · Phone: 508-408-5531
Official record on ClinicalTrials.gov — NCT07659418
Locations in the U.S.
| Massachusetts | CorEvitas, LLC, Waltham |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.